Currently, CVS Health Corp [CVS] is trading at $62.88, up 2.44%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CVS shares have gain 9.22% over the last week, with a monthly amount glided 10.37%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on May 30, 2024, when Robert W. Baird initiated its Neutral rating and assigned the stock a price target of $61. Previously, TD Cowen downgraded its rating to Hold on May 07, 2024, and dropped its price target to $59. On May 02, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $60 on the stock. Leerink Partners downgraded its rating to a Market Perform and decreased its price target to $60 on May 01, 2024. Cantor Fitzgerald downgraded its rating to a Neutral. Barclays started tracking with a Equal Weight rating for this stock on March 06, 2024, and assigned it a price target of $78. In a note dated February 26, 2024, Leerink Partners initiated an Outperform rating and provided a target price of $88 on this stock.
This stock has fluctuated between a low of $52.77 and a high of $83.25 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $103.77 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $62.88 at the most recent close of the market. An investor can expect a potential return of 65.03% based on the average CVS price forecast.
Analyzing the CVS fundamentals
Trailing Twelve Months sales for CVS Health Corp [NYSE:CVS] were 363.65B which represents 2.59% growth. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.1 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.91.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 62.20 points at the first support level, and at 61.52 for the second support level. However, for the 1st resistance point, the stock is sitting at 63.58, and for the 2nd resistance point, it is at 64.28.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CVS Health Corp [NYSE:CVS] is 0.86. Also, the Quick Ratio is 0.66, while the Cash Ratio stands at 0.15. Considering the valuation of this stock, the price to sales ratio is 0.22, the price to book ratio is 1.05 and price to earnings (TTM) ratio is 11.19.
Transactions by insiders
Recent insider trading involved LUDWIG EDWARD J, Director, that happened on May 02 ’24 when 1000.0 shares were purchased. Director, Mahoney Michael F completed a deal on May 02 ’24 to buy 9181.0 shares. Meanwhile, EVP and Pres-Pharm, Consumer W Shah Prem S sold 29473.0 shares on Feb 16 ’24.
